APA

Hagleitner M. M., Coenen M. J. H., Patino-Garcia A., de Bont E. S. J. M., Gonzalez-Neira A., Vos H. I., van Leeuwen F. N., Gelderblom H., Hoogerbrugge P. M., Guchelaar H. & Te Loo M. W. M. (20151001). Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. : PloS one.

Chicago

Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan and Te Loo Maroeska W M. 20151001. Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. : PloS one.

Harvard

Hagleitner M. M., Coenen M. J. H., Patino-Garcia A., de Bont E. S. J. M., Gonzalez-Neira A., Vos H. I., van Leeuwen F. N., Gelderblom H., Hoogerbrugge P. M., Guchelaar H. and Te Loo M. W. M. (20151001). Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. : PloS one.

MLA

Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan and Te Loo Maroeska W M. Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. : PloS one. 20151001.